Recent bioinformatics analysis showed that the expression levels of ribosomal proteins L9 (RPL9) and L26 (RPL26) are downregulated in patients with MI compared with controls.168 Therefore, RPL9 and RPL26 are potential targets for diagnosing or treating MI. This evidence concerns the gene RPL9 and myocardial infarction.